Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-28
DOI
10.1007/s40256-020-00459-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention
- (2020) Binita Shah et al. Circulation-Cardiovascular Interventions
- Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
- (2020) Atsushi Tanaka et al. PLOS MEDICINE
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of available urate-lowering drugs: a critical review
- (2019) Larysa Strilchuk et al. Expert Opinion On Drug Safety
- Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population‐Based Cohort Study and Meta‐Analysis
- (2019) Chi‐Hua Chen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction
- (2019) Thomas Hennessy et al. AMERICAN HEART JOURNAL
- Colchicine as a Novel Therapy for Suppressing Chemokine Production in Patients With an Acute Coronary Syndrome: A Pilot Study
- (2019) Bradley Tucker et al. CLINICAL THERAPEUTICS
- Serum uric acid and fatal myocardial infarction
- (2019) Edoardo Casiglia et al. JOURNAL OF HYPERTENSION
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes
- (2019) Cai-Yan Zou et al. MEDICINE
- Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
- (2019) Chengsheng Ju et al. RHEUMATOLOGY
- The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial
- (2018) Allison G. Hays et al. AMERICAN HEART JOURNAL
- Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
- (2018) Markus Bredemeier et al. BMC Cardiovascular Disorders
- Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study
- (2018) MaryAnn Zhang et al. CIRCULATION
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
- (2018) Kaivan Vaidya et al. JACC-Cardiovascular Imaging
- Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert
- (2018) Hyon Choi et al. Arthritis & Rheumatology
- Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study
- (2018) Benjamin W. Van Tassell et al. CLINICAL CARDIOLOGY
- The Role of Colchicine in Treating Postoperative and Post–Catheter Ablation Atrial Fibrillation
- (2018) Spyridon G. Deftereos et al. CLINICAL THERAPEUTICS
- Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF)
- (2018) Takashi Yokota et al. International Heart Journal
- Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis
- (2017) Carsten Lennerz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Colchicine in cardiovascular disease: an ancient drug with modern tricks
- (2016) David C Tong et al. HEART
- Gout
- (2016) Nicola Dalbeth et al. LANCET
- Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
- (2016) Isla S Mackenzie et al. BMJ Open
- A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
- (2016) Jeffrey Poiley et al. Arthritis & Rheumatology
- Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
- (2015) Daniel H Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats
- (2015) Bhaskar Krishnamurthy et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Anti-Inflammatory Treatment With Colchicine in Acute Myocardial InfarctionClinical Perspective
- (2015) Spyridon Deftereos et al. CIRCULATION
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases
- (2015) Yehuda Adler et al. EUROPEAN HEART JOURNAL
- Allopurinol use and risk of non-fatal acute myocardial infarction
- (2015) Francisco J de Abajo et al. HEART
- Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
- (2015) Shulin Wang et al. Journal of Translational Medicine
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation
- (2014) Massimo Imazio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
- (2013) Spyridon Deftereos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
- (2013) Sushma Rekhraj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
- (2012) Vikram Agarwal et al. Journal of Clinical Hypertension
- Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
- (2012) DARIA B. CRITTENDEN et al. JOURNAL OF RHEUMATOLOGY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction
- (2012) Eswar Krishnan et al. ARTHRITIS RESEARCH & THERAPY
- COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial
- (2010) M. Imazio et al. EUROPEAN HEART JOURNAL
- Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
- (2009) M. A. BECKER et al. JOURNAL OF RHEUMATOLOGY
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
- (2009) H. R. Schumacher et al. RHEUMATOLOGY
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More